FIELD: biochemistry.
SUBSTANCE: disclosed is a method obtaining a purified cell-binding agent - cytotoxic agent conjugate (embodiments). In the first embodiment, the method comprises bringing the cell-binding agent into contact with a cytotoxic agent to form a first mixture, bringing the first mixture into contact with a linker-containing bifunctional crosslinking agent to form a second mixture, bringing the second mixture into contact with a polyvinyl difluoride membrane and treating the second mixture to obtain a purified mixture of the cell-binding agent-cytotoxic agent conjugate. In a second embodiment, the method comprises bringing the cell-binding agent into contact with a linker-containing bifunctional cross-linking agent to produce a first mixture, treating the first mixture to produce a purified first mixture, conjugating a cytotoxic agent with bound linker-containing cell-binding agents to obtain a second mixture, bringing the second mixture into contact with a polyvinyl difluoride membrane and treating the second mixture to obtain a purified mixture of the cell-binding agent-cytotoxic agent conjugate. In a third embodiment, the method comprises bringing the cell-binding agent into contact with a linker-containing bifunctional cross-linking agent to form a first mixture, conjugating a cytotoxic agent with bound linker-containing cell-binding agents to obtain a second mixture, bringing the second mixture into contact with a polyvinyl difluoride membrane and treating the purified second mixture to obtain a purified cell-binding agent-cytotoxic agent conjugate mixture.
EFFECT: invention enables preparation of a cell-binding agent-cytotoxic agent conjugate with higher purity and stability.
178 cl, 2 dwg, 3 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING CONJUGATES OF CELL-BINDING AGENT AND CYTOTOXIC AGENT | 2015 |
|
RU2711930C2 |
CREATION OF CONJUGATES OF GD2-SPECIFIC ANTIBODIES AND FRAGMENTS OF GD2-SPECIFIC ANTIBODIES WITH PREPARATIONS | 2019 |
|
RU2733430C1 |
METHODS FOR PREPARING ANTIBODY-DRUG CONJUGATE COMPOSITIONS | 2015 |
|
RU2741470C2 |
CD37-BINDING MOLECULES AND THEIR IMMUNOCONJUGATES | 2011 |
|
RU2742743C2 |
ANTIBODIES AGAINST FOLIC ACID RECEPTOR 1, THEIR IMMUNOCONJUGATES AND USE | 2011 |
|
RU2740479C2 |
ANTI-CD79B ANTIBODIES, IMMUNOCONJUGATES AND METHODS FOR THEIR USE | 2019 |
|
RU2791984C2 |
NEW ANTI-CD19 ANTIBODIES | 2018 |
|
RU2791445C2 |
DIAGNOSTICS AND TREATMENT OF CANCER ASSOCIATED WITH CANCER STEM CELLS | 2014 |
|
RU2749867C2 |
CONJUGATES OF ANTIBODY TO CCR7 AND DRUG | 2018 |
|
RU2777662C2 |
METHODS OF OBTAINING, PURIFICATION AND COMPOSING OF ANTIBODY-DRUG CONJUGATES | 2019 |
|
RU2801229C2 |
Authors
Dates
2018-07-11—Published
2013-10-04—Filed